Prime Medicine, Inc. (PRME)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.70-0.27%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PRME
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | 4.6 | 3.0 | 0.0 | 0.0 | 0.0 | 5.2 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 146.2 | 160.6 | 155.3 | 147.9 | 86.7 | 70.6 | 3.0 |
| Operating Income | (196.5) | (208.4) | (202.5) | (204.8) | (116.5) | (84.5) | (0.9) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 4.0 | 4.1 | 3.5 | 2.8 | — | — | — |
| Other Non-Operating Income / Expenses | 8.6 | 7.2 | 6.6 | 6.4 | (6.2) | (81.4) | (0.6) |
| Income Tax Expense | — | — | — | (0.3) | (0.9) | (0.5) | 1.9 |
| Net Income | |||||||
| Net Income | (187.9) | (201.1) | (195.9) | (198.1) | (121.8) | (165.4) | (3.4) |
| Per Share | |||||||
| Basic EPS | (1.06) | (1.35) | (1.65) | (2.18) | (4.19) | (14.19) | (1.91) |
| Diluted EPS | (1.06) | (1.35) | (1.65) | (2.18) | (4.19) | (14.19) | (1.91) |
| Basic Weighted Avg Shares | 177.2 | 148.8 | 118.6 | 91.0 | 33.9 | 13.0 | 2.6 |
| Diluted Weighted Avg Shares | 177.2 | 148.8 | 118.6 | 91.0 | 33.9 | 13.0 | 2.6 |
| Supplemental | |||||||
| EBITDA | — | (201.0) | (196.3) | (200.1) | (114.3) | (83.9) | (0.9) |
| EBIT | (196.5) | (208.4) | (202.5) | (204.8) | (116.5) | (84.5) | (0.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.